“If you don’t have an IT company (in your portfolio), it’s like having a portfolio in the industrial revolution that doesn’t have steam engine technology,” says Mukherjea
MonoFerric is indicated for the treatment of iron deficiency in adult patients when oral iron preparations are ineffective or cannot be used or where there is a clinical need to deliver iron rapidly, the company said in a regulatory filing.
European bourses close lower as investors continued to dwell on the recessionary outlook in the region and as inflationary pressures continue to grow. Stoxx 600 ended the day 0.4% lower. Stock in the spotlight today - InterGlobe Aviation, Blue Star, Zydus Lifesciences and Capacite Infra We also explore the key reasons responsible for the pharma sector’s underperformance.
Nifty 50 and Sensex have made a tentative start to the week in the past two sessions making investors jittery. Watch as CJ discusses what lies in store for Nifty 50 and what are the crucial levels you need to track in the coming days for your trade. Plus his thoughts on IndusInd Bank, Tata Steel, and BEML.
European markets close marginally higher as investors continued to assess recession risks in the region. Stoxx 600 ended with gains of 0.2%, and the majority of sectors and all major bourses are in the green. Stocks in the spotlight today - InterGlobe Aviation, Hatsun Agro, Syngene International and Astral. We also explore the key reasons for the pharma sector’s underperformance.
The Supreme Court on Thursday was told by an NGO that the Central Board of Direct Taxes has accused the Bengaluru-based drug firm of distributing Rs 1,000 crore freebies to doctors for prescribing its 650 mg tablets.
The Drugs Controller General of India (DCGI) has approved Lynparza (Olaparib) as a monotherapy for the treatment of adult patients with early breast cancer.
Shares of Divi's have been under pressure this fiscal, as margin are weighed down by input cost, China lockdowns, and a spike in freight rates.
Information technology, pharmaceutical and textile industries may benefit because they are net exporters. Oil and gas and aviation are some of the sectors which will have a negative impact on the rupee weakness.
Uflex is well-positioned to catapult into the next growth phase given resilient end-markets and sustainable manufacturing initiatives. MC Pro suggests investors to consider it as a long-term buying opportunity. Should you buy? Watch the video to find out.
The company's pharma vertical is expected to have nearly 15 per cent CAGR revenue growth across businesses in the medium to long-term, Piramal said.
Attrition continues to be high in sectors like IT (22%), educational services (13.11%), healthcare and pharma (12.25%) and ecommerce (11.04%) .
So far, the scheme has seen maximum response from the electronics, auto components, and pharma sectors, according to Emkay Investment Managers
Sastasundar Ventures' stock has plunged over 50 percent from its all-time high in November’21, even though the business remains largely unaffected by ongoing market condition. MC Pro suggests growth outlook appears very promising from a long-term standpoint. Watch the video to find out why.
With the rising prevalence of chronic diseases and growth of biologics, MC Pro recommends holding Gland Pharma. Post the recent correction and downward adjustments in estimates, Gland Pharma is trading at 17x EV/EBITDA for FY24e. Here’s why it makes for a good investment bet.
The brokerage expects Sun Pharma growth to be driven by its speciality portfolio and India market from hereon
Sensex tanked more than 1,000 points to close at 54,303 and Nifty ended at 16,202. All sectoral and broader indices came under pressure with Nifty Bank, IT, Financial Services ending up as the biggest losers.
Benchmark indices ended the session on a positive note with the Sensex gaining 437 points, and the Nifty adding 105 points. Reliance surged over three percent to close at one-month high. The midcap index ended flat while the small-cap index closed with gains of half a percent.
According to a report released on Wednesday, capital investment in the manufacturing sector is on track to increase as a result of overwhelming reactions to the government's production-linked incentive schemes, particularly in the lithium-ion battery, pharmaceutical, and solar module segments.
Coming up on markets with #SantoAndCJ at 3 PM | #ICYMI What early 2000s can tell you about bear market rallies? Also, Santo & CJ’s take on DLF, 3M India, Atul Auto, Sudarshan Chemicals and Granules India.
Nifty 50 closed above the 20 DMA on Friday and is likely to cross the 16,400 level. Also, know why Santo and CJ are tracking M&M, JSW Steel, Tata Power, TNS Clothing, and Nykaa.
Benchmark indices ended higher for the second consecutive day on May 27. At close, the Sensex was up 632.13 points or 1.17% at 54,884.66, and the Nifty was up 182.30 points or 1.13% at 16,352.50. Here’s the round-up of all the day’s action with Yatin Mota.
After seeing a downtrend for three straight days, the Indian equity benchmarks ended higher on May 26 as buying in metal, IT, power, realty and banking stocks supported the market. Here’s a round-up of all the day’s action with Yatin Mota.
India's price monitoring committee will meet and hold discussions on major food products after the government banned wheat exports. As per sources, non-basmati rice exports might also be restricted. Will this lead to a rise in the prices of rice? Manisha Gupta brings you the details
Indian equity benchmark ended lower for the third consecutive day today, pulled down by a selloff in information technology, metal and realty names. At close, the Sensex was down 303.35 points, or 0.56 percent, at 53,749.26, and the Nifty was down 99.40 points, or 0.62 percent, at 16,025.80. Here's a wrap of today's market action with Yatin Mota.